Cancer Res (2023) 83 (7_Supplement): ND02.
Abstract. Effects of prolonging adjuvant aromatase inhibitor therapy beyond five years on recurrence and cause-specific mortality: an EBCTCG meta-analysis of individual patient data from 12 randomised ...
Cancer Res (2022) 82 (12_Supplement): 3595. Combination treatment with RMC-6291 and SHP2 or SOS1 inhibitors was well tolerated in preclinical models and further increased anti-tumor activity, likely ...
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
1Surveillance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia. *Corresponding Author: Elizabeth J. Schafer, Surveillance ...
Background:. A critical component of oncogenesis and cancer progression is metabolic re-programming of cells to enable continuous growth. Oncogenic activated signaling pathways can drive de novo ...
1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.
1Basser Center for BRCA1/2, University of Pennsylvania, Philadelphia, Pennsylvania. 2Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Cancer Research | 80 | 16_Supplement | August 2020Journal Archive Cancer Research (1941-Present; volumes 1-current) Published twice monthly since 1987. From 1941-1986, published monthly. (ISSN ...
Cancer Res (2023) 83 (8_Supplement): LB031.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback